Moreover, the finding that Blimp1-deficient TFR cells displayed TH17 phenotype and expressed elevated levels of TH17 cytokines may provide partial explanations for the reported increased TH17-like phenotype with reduced suppressive function by circulating TFR cells in MS patients compared to HC [14]. This evidence concerns the gene PRDM1 and myeloid sarcoma.